Search results for "Nabilone"

showing 1 items of 1 documents

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

2009

Both agonists (e.g. Delta(9)-tetrahydrocannabinol, nabilone) and antagonists (e.g. rimonabant, taranabant) of the cannabinoid type-1 (CB(1)) receptor have been explored as therapeutic agents in diverse fields of medicine such as pain management and obesity with associated metabolic dysregulation, respectively. CB(1) receptors are widely distributed in the central nervous system and are involved in the modulation of emotion, stress and habituation responses, behaviours that are thought to be dysregulated in human psychiatric disorders. Accordingly, CB(1) receptor activation may, in some cases, precipitate episodes of psychosis and panic, while its inhibition may lead to behaviours reminiscen…

PsychosisCannabinoid receptorEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPharmacologyEndocrinologyTaranabantPiperidinesReceptor Cannabinoid CB1RimonabantCannabinoid Receptor ModulatorsmedicineAnimalsHumansDronabinolDepressive Disorderbusiness.industryCannabinoid Receptor Agonistsmedicine.diseaseAnxiety DisordersEndocannabinoid systemNabiloneAffectPyrazolesCannabinoidRimonabantbusinessNeurosciencemedicine.drugBest Practice & Research Clinical Endocrinology & Metabolism
researchProduct